Skip to main content
Smart Investors Daily
OF

NASDAQ · OFIX

Orthofix Medical Inc.

Healthcare · Medical - Devices

$6.80

Down-$0.37 (-5.16%)

Updated Nov 17, 2026, 2:37 AM

SID Score

3.4/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
622.51M
P/E ratio
-5.25
Dividend yield
0.00%
52-week range
$6.52 – $16.42
Volume
604.2K
Avg. volume
261.03K

Price performance · OFIX

OFIX price history

1M range · 21 trading sessions · Daily adjusted prices

Prices through Nov 16, 2026

OFIX closed at $6.80 after 21 trading sessions, down 29.09% for the selected period.

Last close
$6.80
Period change
-29.09%
Period low
$6.80
Period high
$10.24
Daily close
View OHLC price history
OFIX OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Nov 16, 2026$7.08$7.15$6.775$6.80604.2K
Nov 13, 2026$7.19$7.3164$7.09$7.17553.15K
Nov 12, 2026$7.20$7.39$6.825$6.94560.22K
Nov 11, 2026$7.02$7.40$6.94$7.18763.52K
Nov 10, 2026$7.75$7.80$7.06$7.12940.06K
Nov 9, 2026$7.01$8.03$6.52$7.902.69M
Nov 6, 2026$8.68$8.68$7.81$7.87805.84K
Nov 5, 2026$9.95$10.04$8.645$8.921.36M
Nov 4, 2026$9.06$9.825$9.01$9.721.17M
Nov 3, 2026$8.72$8.85$8.55$8.76402.15K
Nov 2, 2026$9.07$9.255$8.7001$8.75565.63K
Oct 30, 2026$10.29$10.29$8.895$9.07657.86K
Oct 29, 2026$10.22$10.57$10.125$10.24399.26K
Oct 28, 2026$9.67$10.16$9.67$10.04294.99K
Oct 27, 2026$9.67$9.94$9.65$9.71301.19K
Oct 26, 2026$9.65$9.83$9.645$9.78200.6K
Oct 23, 2026$9.92$9.99$9.67$9.81247.6K
Oct 22, 2026$9.79$10.0583$9.79$9.99336.77K
Oct 21, 2026$9.71$9.94$9.64$9.74604.96K
Oct 20, 2026$9.68$9.95$9.68$9.85335.29K
Oct 19, 2026$9.34$9.665$9.2848$9.59296.09K

Latest OFIX news

The latest Smart Investors Daily articles mentioning OFIX.

OFIX research

Overview

Company profile and research snapshot.

Company profile

Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two main segments: global spine, including bone growth and healing therapies, spinal implants, and regenerative tissue products; and global orthopedics, providing products used in fracture repair, deformity correction, and bone reconstruction procedures. The majority of the company's sales come from the global spine segment in the United States. Orthofix distributes its products throughout North America, Europe, and several countries across the globe. The company provides solutions to hospitals, physicians, other healthcare providers, and patients.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
$20.00
Implied upside
—
Analysts
—
OFIX recent ratings
DateFirmRatingTarget
Aug 10, 2026Canaccord GenuityBuy—
Jul 6, 2026Barrington ResearchOutperform—
May 22, 2026Canaccord GenuityBuy—
May 22, 2026Barrington ResearchOutperform—
May 22, 2026StifelBuy—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Nov 9, 2026

Orthofix Medical Q3 Earnings Call Highlights

Orthofix Medical (NASDAQ:OFIX) lowered its 2026 outlook after third-quarter results fell short of management’s expectations, as softer U.S. spine procedure volumes and supplier delays constrained its ability to support demand. Third-quarter net sales were $207.9 million, up 2.3% year over year, wit

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.